BiotechTube
Home/Nanopharmaceutics/Judy Talton, MS, ARNP
JT

Judy Talton, MS, ARNP

Chief Clinical Officer & acting Chief Financial Officer

Nanopharmaceutics

Roles

Chief Clinical Officer & acting Chief Financial OfficeratNanopharmaceutics
Chief Operating Officer and Chief Financial OfficeratAlchem Laboratories

Therapeutic Areas

OncologyCentral Nervous System (CNS) DisordersDiabetesInfectious Diseases

Nanopharmaceutics Pipeline

DrugIndicationPhase
Triapine®CancerClinical
Ammonium TetrathiomolybdateCancerClinical
Aza-TdCCancerClinical
NanoBUP™CNS DisordersClinical
PRX-3140CNS DisordersClinical
NP-18-2CNS DisordersClinical
NP-18-3CNS DisordersClinical
Ramoplanin™Infectious DiseasesClinical

Leadership Team at Nanopharmaceutics

JD
James D. Talton, Ph.D.
President & CEO (of parent TRON Group Inc. and subsidiaries)
View full Nanopharmaceutics profile